nodes	percent_of_prediction	percent_of_DWPC	metapath
Isosorbide Mononitrate—Isosorbide Dinitrate—CYP2E1—liver cancer	0.0266	1	CrCbGaD
Isosorbide Mononitrate—CYP3A4—Felbamate Metabolism—CYP2E1—liver cancer	0.00454	0.0537	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Liver X Receptor Pathway—SCD—liver cancer	0.00273	0.0323	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—HBE1—liver cancer	0.00246	0.0291	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—HBE1—liver cancer	0.00246	0.0291	CbGpPWpGaD
Isosorbide Mononitrate—Abnormal vision—Epirubicin—liver cancer	0.00241	0.00271	CcSEcCtD
Isosorbide Mononitrate—Mental disability—Epirubicin—liver cancer	0.0024	0.0027	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Sorafenib—liver cancer	0.00238	0.00268	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Sorafenib—liver cancer	0.00235	0.00264	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—ATF3—liver cancer	0.00233	0.0276	CbGpPWpGaD
Isosorbide Mononitrate—Decreased appetite—Sorafenib—liver cancer	0.00232	0.00261	CcSEcCtD
Isosorbide Mononitrate—Diabetes mellitus—Epirubicin—liver cancer	0.00231	0.00259	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Sorafenib—liver cancer	0.0023	0.00259	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Sorafenib—liver cancer	0.0023	0.00259	CcSEcCtD
Isosorbide Mononitrate—Constipation—Sorafenib—liver cancer	0.00228	0.00257	CcSEcCtD
Isosorbide Mononitrate—Pain—Sorafenib—liver cancer	0.00228	0.00257	CcSEcCtD
Isosorbide Mononitrate—Vascular purpura—Epirubicin—liver cancer	0.00224	0.00252	CcSEcCtD
Isosorbide Mononitrate—Eczema—Epirubicin—liver cancer	0.00223	0.00251	CcSEcCtD
Isosorbide Mononitrate—Abnormal vision—Doxorubicin—liver cancer	0.00223	0.00251	CcSEcCtD
Isosorbide Mononitrate—Mental disability—Doxorubicin—liver cancer	0.00222	0.0025	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—HBE1—liver cancer	0.00219	0.0259	CbGpPWpGaD
Isosorbide Mononitrate—Gastrointestinal pain—Sorafenib—liver cancer	0.00218	0.00245	CcSEcCtD
Isosorbide Mononitrate—Hot flush—Epirubicin—liver cancer	0.00214	0.00241	CcSEcCtD
Isosorbide Mononitrate—Increased appetite—Epirubicin—liver cancer	0.00213	0.0024	CcSEcCtD
Isosorbide Mononitrate—Diabetes mellitus—Doxorubicin—liver cancer	0.00213	0.0024	CcSEcCtD
Isosorbide Mononitrate—Menopausal symptoms—Epirubicin—liver cancer	0.00213	0.00239	CcSEcCtD
Isosorbide Mononitrate—GUCY1B3—Platelet homeostasis—MAPK14—liver cancer	0.00212	0.0251	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Platelet homeostasis—MAPK14—liver cancer	0.00212	0.0251	CbGpPWpGaD
Isosorbide Mononitrate—Abdominal pain—Sorafenib—liver cancer	0.00211	0.00237	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Sorafenib—liver cancer	0.00211	0.00237	CcSEcCtD
Isosorbide Mononitrate—Purpura—Epirubicin—liver cancer	0.00208	0.00234	CcSEcCtD
Isosorbide Mononitrate—Vascular purpura—Doxorubicin—liver cancer	0.00207	0.00233	CcSEcCtD
Isosorbide Mononitrate—Eczema—Doxorubicin—liver cancer	0.00207	0.00232	CcSEcCtD
Isosorbide Mononitrate—Cardiac failure—Epirubicin—liver cancer	0.00206	0.00231	CcSEcCtD
Isosorbide Mononitrate—Cerebrovascular accident—Epirubicin—liver cancer	0.00205	0.0023	CcSEcCtD
Isosorbide Mononitrate—Diplopia—Epirubicin—liver cancer	0.00201	0.00226	CcSEcCtD
Isosorbide Mononitrate—Osteoarthritis—Epirubicin—liver cancer	0.00201	0.00226	CcSEcCtD
Isosorbide Mononitrate—Hot flush—Doxorubicin—liver cancer	0.00198	0.00223	CcSEcCtD
Isosorbide Mononitrate—Increased appetite—Doxorubicin—liver cancer	0.00198	0.00222	CcSEcCtD
Isosorbide Mononitrate—Affect lability—Epirubicin—liver cancer	0.00197	0.00222	CcSEcCtD
Isosorbide Mononitrate—Migraine—Epirubicin—liver cancer	0.00197	0.00222	CcSEcCtD
Isosorbide Mononitrate—Menopausal symptoms—Doxorubicin—liver cancer	0.00197	0.00221	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Sorafenib—liver cancer	0.00197	0.00221	CcSEcCtD
Isosorbide Mononitrate—Purpura—Doxorubicin—liver cancer	0.00193	0.00217	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Sorafenib—liver cancer	0.00191	0.00215	CcSEcCtD
Isosorbide Mononitrate—Cardiac failure—Doxorubicin—liver cancer	0.0019	0.00214	CcSEcCtD
Isosorbide Mononitrate—Mood swings—Epirubicin—liver cancer	0.0019	0.00214	CcSEcCtD
Isosorbide Mononitrate—Cerebrovascular accident—Doxorubicin—liver cancer	0.00189	0.00213	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Platelet homeostasis—MAPK14—liver cancer	0.00189	0.0224	CbGpPWpGaD
Isosorbide Mononitrate—Pruritus—Sorafenib—liver cancer	0.00189	0.00212	CcSEcCtD
Isosorbide Mononitrate—Diplopia—Doxorubicin—liver cancer	0.00186	0.00209	CcSEcCtD
Isosorbide Mononitrate—Osteoarthritis—Doxorubicin—liver cancer	0.00186	0.00209	CcSEcCtD
Isosorbide Mononitrate—Orthostatic hypotension—Epirubicin—liver cancer	0.00183	0.00206	CcSEcCtD
Isosorbide Mononitrate—Affect lability—Doxorubicin—liver cancer	0.00183	0.00206	CcSEcCtD
Isosorbide Mononitrate—Migraine—Doxorubicin—liver cancer	0.00183	0.00206	CcSEcCtD
Isosorbide Mononitrate—Hypokalaemia—Epirubicin—liver cancer	0.00183	0.00205	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Sorafenib—liver cancer	0.00183	0.00205	CcSEcCtD
Isosorbide Mononitrate—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00181	0.00203	CcSEcCtD
Isosorbide Mononitrate—Gastritis—Epirubicin—liver cancer	0.00178	0.002	CcSEcCtD
Isosorbide Mononitrate—Muscular weakness—Epirubicin—liver cancer	0.00177	0.00199	CcSEcCtD
Isosorbide Mononitrate—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00177	0.00199	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Sorafenib—liver cancer	0.00176	0.00198	CcSEcCtD
Isosorbide Mononitrate—Mood swings—Doxorubicin—liver cancer	0.00176	0.00198	CcSEcCtD
Isosorbide Mononitrate—Asthma—Epirubicin—liver cancer	0.00173	0.00195	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Sorafenib—liver cancer	0.0017	0.00191	CcSEcCtD
Isosorbide Mononitrate—Orthostatic hypotension—Doxorubicin—liver cancer	0.0017	0.00191	CcSEcCtD
Isosorbide Mononitrate—Hypokalaemia—Doxorubicin—liver cancer	0.00169	0.0019	CcSEcCtD
Isosorbide Mononitrate—Angina pectoris—Epirubicin—liver cancer	0.00169	0.0019	CcSEcCtD
Isosorbide Mononitrate—Rash—Sorafenib—liver cancer	0.00168	0.00189	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Sorafenib—liver cancer	0.00168	0.00189	CcSEcCtD
Isosorbide Mononitrate—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00167	0.00188	CcSEcCtD
Isosorbide Mononitrate—Headache—Sorafenib—liver cancer	0.00167	0.00188	CcSEcCtD
Isosorbide Mononitrate—Bronchitis—Epirubicin—liver cancer	0.00167	0.00188	CcSEcCtD
Isosorbide Mononitrate—Gastritis—Doxorubicin—liver cancer	0.00164	0.00185	CcSEcCtD
Isosorbide Mononitrate—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00164	0.00184	CcSEcCtD
Isosorbide Mononitrate—Muscular weakness—Doxorubicin—liver cancer	0.00164	0.00184	CcSEcCtD
Isosorbide Mononitrate—Dysuria—Epirubicin—liver cancer	0.00162	0.00182	CcSEcCtD
Isosorbide Mononitrate—Upper respiratory tract infection—Epirubicin—liver cancer	0.00161	0.00181	CcSEcCtD
Isosorbide Mononitrate—Asthma—Doxorubicin—liver cancer	0.0016	0.0018	CcSEcCtD
Isosorbide Mononitrate—Pollakiuria—Epirubicin—liver cancer	0.0016	0.0018	CcSEcCtD
Isosorbide Mononitrate—Nausea—Sorafenib—liver cancer	0.00158	0.00178	CcSEcCtD
Isosorbide Mononitrate—Weight increased—Epirubicin—liver cancer	0.00158	0.00177	CcSEcCtD
Isosorbide Mononitrate—Weight decreased—Epirubicin—liver cancer	0.00157	0.00176	CcSEcCtD
Isosorbide Mononitrate—Angina pectoris—Doxorubicin—liver cancer	0.00156	0.00176	CcSEcCtD
Isosorbide Mononitrate—Pneumonia—Epirubicin—liver cancer	0.00155	0.00175	CcSEcCtD
Isosorbide Mononitrate—Bronchitis—Doxorubicin—liver cancer	0.00154	0.00174	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—PRKCE—liver cancer	0.00152	0.018	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—ANXA2—liver cancer	0.00152	0.018	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—ANXA2—liver cancer	0.00152	0.018	CbGpPWpGaD
Isosorbide Mononitrate—Neuropathy peripheral—Epirubicin—liver cancer	0.00152	0.0017	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.0015	0.0178	CbGpPWpGaD
Isosorbide Mononitrate—Urinary tract infection—Epirubicin—liver cancer	0.0015	0.00169	CcSEcCtD
Isosorbide Mononitrate—Conjunctivitis—Epirubicin—liver cancer	0.0015	0.00169	CcSEcCtD
Isosorbide Mononitrate—Dysuria—Doxorubicin—liver cancer	0.0015	0.00169	CcSEcCtD
Isosorbide Mononitrate—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00149	0.00168	CcSEcCtD
Isosorbide Mononitrate—Sweating—Epirubicin—liver cancer	0.00148	0.00167	CcSEcCtD
Isosorbide Mononitrate—Pollakiuria—Doxorubicin—liver cancer	0.00148	0.00167	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.00148	0.0175	CbGpPWpGaD
Isosorbide Mononitrate—Haematuria—Epirubicin—liver cancer	0.00147	0.00166	CcSEcCtD
Isosorbide Mononitrate—Weight increased—Doxorubicin—liver cancer	0.00146	0.00164	CcSEcCtD
Isosorbide Mononitrate—Epistaxis—Epirubicin—liver cancer	0.00146	0.00164	CcSEcCtD
Isosorbide Mononitrate—Weight decreased—Doxorubicin—liver cancer	0.00145	0.00163	CcSEcCtD
Isosorbide Mononitrate—Sinusitis—Epirubicin—liver cancer	0.00145	0.00163	CcSEcCtD
Isosorbide Mononitrate—Pneumonia—Doxorubicin—liver cancer	0.00144	0.00162	CcSEcCtD
Isosorbide Mononitrate—Bradycardia—Epirubicin—liver cancer	0.00141	0.00159	CcSEcCtD
Isosorbide Mononitrate—Neuropathy peripheral—Doxorubicin—liver cancer	0.0014	0.00158	CcSEcCtD
Isosorbide Mononitrate—Haemoglobin—Epirubicin—liver cancer	0.00139	0.00157	CcSEcCtD
Isosorbide Mononitrate—Rhinitis—Epirubicin—liver cancer	0.00139	0.00157	CcSEcCtD
Isosorbide Mononitrate—Conjunctivitis—Doxorubicin—liver cancer	0.00139	0.00156	CcSEcCtD
Isosorbide Mononitrate—Urinary tract infection—Doxorubicin—liver cancer	0.00139	0.00156	CcSEcCtD
Isosorbide Mononitrate—Haemorrhage—Epirubicin—liver cancer	0.00139	0.00156	CcSEcCtD
Isosorbide Mononitrate—Hypoaesthesia—Epirubicin—liver cancer	0.00138	0.00155	CcSEcCtD
Isosorbide Mononitrate—Pharyngitis—Epirubicin—liver cancer	0.00138	0.00155	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Farnesoid X Receptor  Pathway—NR1H4—liver cancer	0.00138	0.0163	CbGpPWpGaD
Isosorbide Mononitrate—Sweating—Doxorubicin—liver cancer	0.00137	0.00154	CcSEcCtD
Isosorbide Mononitrate—Urinary tract disorder—Epirubicin—liver cancer	0.00137	0.00154	CcSEcCtD
Isosorbide Mononitrate—Oedema peripheral—Epirubicin—liver cancer	0.00137	0.00154	CcSEcCtD
Isosorbide Mononitrate—Haematuria—Doxorubicin—liver cancer	0.00136	0.00153	CcSEcCtD
Isosorbide Mononitrate—Urethral disorder—Epirubicin—liver cancer	0.00136	0.00153	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—ANXA2—liver cancer	0.00136	0.016	CbGpPWpGaD
Isosorbide Mononitrate—Epistaxis—Doxorubicin—liver cancer	0.00135	0.00152	CcSEcCtD
Isosorbide Mononitrate—Sinusitis—Doxorubicin—liver cancer	0.00134	0.00151	CcSEcCtD
Isosorbide Mononitrate—Visual impairment—Epirubicin—liver cancer	0.00134	0.0015	CcSEcCtD
Isosorbide Mononitrate—Bradycardia—Doxorubicin—liver cancer	0.00131	0.00147	CcSEcCtD
Isosorbide Mononitrate—Tinnitus—Epirubicin—liver cancer	0.00129	0.00146	CcSEcCtD
Isosorbide Mononitrate—Haemoglobin—Doxorubicin—liver cancer	0.00129	0.00145	CcSEcCtD
Isosorbide Mononitrate—Cardiac disorder—Epirubicin—liver cancer	0.00129	0.00145	CcSEcCtD
Isosorbide Mononitrate—Flushing—Epirubicin—liver cancer	0.00129	0.00145	CcSEcCtD
Isosorbide Mononitrate—Rhinitis—Doxorubicin—liver cancer	0.00129	0.00145	CcSEcCtD
Isosorbide Mononitrate—Haemorrhage—Doxorubicin—liver cancer	0.00128	0.00144	CcSEcCtD
Isosorbide Mononitrate—Hypoaesthesia—Doxorubicin—liver cancer	0.00128	0.00144	CcSEcCtD
Isosorbide Mononitrate—Pharyngitis—Doxorubicin—liver cancer	0.00127	0.00143	CcSEcCtD
Isosorbide Mononitrate—Urinary tract disorder—Doxorubicin—liver cancer	0.00127	0.00143	CcSEcCtD
Isosorbide Mononitrate—Oedema peripheral—Doxorubicin—liver cancer	0.00126	0.00142	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.00126	0.0149	CbGpPWpGaD
Isosorbide Mononitrate—Urethral disorder—Doxorubicin—liver cancer	0.00126	0.00142	CcSEcCtD
Isosorbide Mononitrate—Chills—Epirubicin—liver cancer	0.00125	0.0014	CcSEcCtD
Isosorbide Mononitrate—Arrhythmia—Epirubicin—liver cancer	0.00124	0.00139	CcSEcCtD
Isosorbide Mononitrate—Visual impairment—Doxorubicin—liver cancer	0.00124	0.00139	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Epirubicin—liver cancer	0.00122	0.00137	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Estrogen metabolism—GSTA1—liver cancer	0.00121	0.0144	CbGpPWpGaD
Isosorbide Mononitrate—Malnutrition—Epirubicin—liver cancer	0.00121	0.00136	CcSEcCtD
Isosorbide Mononitrate—Tinnitus—Doxorubicin—liver cancer	0.0012	0.00135	CcSEcCtD
Isosorbide Mononitrate—Cardiac disorder—Doxorubicin—liver cancer	0.00119	0.00134	CcSEcCtD
Isosorbide Mononitrate—Flushing—Doxorubicin—liver cancer	0.00119	0.00134	CcSEcCtD
Isosorbide Mononitrate—Flatulence—Epirubicin—liver cancer	0.00119	0.00134	CcSEcCtD
Isosorbide Mononitrate—Tension—Epirubicin—liver cancer	0.00119	0.00133	CcSEcCtD
Isosorbide Mononitrate—Dysgeusia—Epirubicin—liver cancer	0.00118	0.00133	CcSEcCtD
Isosorbide Mononitrate—Nervousness—Epirubicin—liver cancer	0.00117	0.00132	CcSEcCtD
Isosorbide Mononitrate—Back pain—Epirubicin—liver cancer	0.00117	0.00131	CcSEcCtD
Isosorbide Mononitrate—Muscle spasms—Epirubicin—liver cancer	0.00116	0.00131	CcSEcCtD
Isosorbide Mononitrate—Chills—Doxorubicin—liver cancer	0.00115	0.0013	CcSEcCtD
Isosorbide Mononitrate—Arrhythmia—Doxorubicin—liver cancer	0.00115	0.00129	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Epirubicin—liver cancer	0.00114	0.00128	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Doxorubicin—liver cancer	0.00112	0.00127	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Epirubicin—liver cancer	0.00112	0.00126	CcSEcCtD
Isosorbide Mononitrate—Malnutrition—Doxorubicin—liver cancer	0.00112	0.00126	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Epirubicin—liver cancer	0.00112	0.00126	CcSEcCtD
Isosorbide Mononitrate—Agitation—Epirubicin—liver cancer	0.00111	0.00125	CcSEcCtD
Isosorbide Mononitrate—Flatulence—Doxorubicin—liver cancer	0.0011	0.00124	CcSEcCtD
Isosorbide Mononitrate—Tension—Doxorubicin—liver cancer	0.0011	0.00123	CcSEcCtD
Isosorbide Mononitrate—Dysgeusia—Doxorubicin—liver cancer	0.00109	0.00123	CcSEcCtD
Isosorbide Mononitrate—Malaise—Epirubicin—liver cancer	0.00109	0.00123	CcSEcCtD
Isosorbide Mononitrate—Nervousness—Doxorubicin—liver cancer	0.00109	0.00122	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Epirubicin—liver cancer	0.00109	0.00122	CcSEcCtD
Isosorbide Mononitrate—Syncope—Epirubicin—liver cancer	0.00108	0.00122	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Epirubicin—liver cancer	0.00108	0.00122	CcSEcCtD
Isosorbide Mononitrate—Back pain—Doxorubicin—liver cancer	0.00108	0.00122	CcSEcCtD
Isosorbide Mononitrate—Muscle spasms—Doxorubicin—liver cancer	0.00107	0.00121	CcSEcCtD
Isosorbide Mononitrate—Palpitations—Epirubicin—liver cancer	0.00107	0.0012	CcSEcCtD
Isosorbide Mononitrate—Loss of consciousness—Epirubicin—liver cancer	0.00106	0.00119	CcSEcCtD
Isosorbide Mononitrate—Cough—Epirubicin—liver cancer	0.00105	0.00119	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Doxorubicin—liver cancer	0.00105	0.00119	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Epirubicin—liver cancer	0.00104	0.00117	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Doxorubicin—liver cancer	0.00104	0.00117	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Doxorubicin—liver cancer	0.00103	0.00116	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Epirubicin—liver cancer	0.00103	0.00116	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Epirubicin—liver cancer	0.00103	0.00116	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Epirubicin—liver cancer	0.00103	0.00116	CcSEcCtD
Isosorbide Mononitrate—Agitation—Doxorubicin—liver cancer	0.00103	0.00116	CcSEcCtD
Isosorbide Mononitrate—Anxiety—Epirubicin—liver cancer	0.00102	0.00115	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Epirubicin—liver cancer	0.00102	0.00114	CcSEcCtD
Isosorbide Mononitrate—Malaise—Doxorubicin—liver cancer	0.00101	0.00113	CcSEcCtD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—SERPINA1—liver cancer	0.00101	0.0119	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—SERPINA1—liver cancer	0.00101	0.0119	CbGpPWpGaD
Isosorbide Mononitrate—Dry mouth—Epirubicin—liver cancer	0.00101	0.00113	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Doxorubicin—liver cancer	0.001	0.00113	CcSEcCtD
Isosorbide Mononitrate—Syncope—Doxorubicin—liver cancer	0.001	0.00113	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Doxorubicin—liver cancer	0.001	0.00113	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Epirubicin—liver cancer	0.000994	0.00112	CcSEcCtD
Isosorbide Mononitrate—Palpitations—Doxorubicin—liver cancer	0.000988	0.00111	CcSEcCtD
Isosorbide Mononitrate—Oedema—Epirubicin—liver cancer	0.000986	0.00111	CcSEcCtD
Isosorbide Mononitrate—Loss of consciousness—Doxorubicin—liver cancer	0.000982	0.00111	CcSEcCtD
Isosorbide Mononitrate—Infection—Epirubicin—liver cancer	0.000979	0.0011	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.000979	0.0116	CbGpPWpGaD
Isosorbide Mononitrate—Cough—Doxorubicin—liver cancer	0.000975	0.0011	CcSEcCtD
Isosorbide Mononitrate—Shock—Epirubicin—liver cancer	0.00097	0.00109	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Epirubicin—liver cancer	0.000967	0.00109	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Epirubicin—liver cancer	0.000965	0.00109	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Doxorubicin—liver cancer	0.000965	0.00109	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Epirubicin—liver cancer	0.000962	0.00108	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Epirubicin—liver cancer	0.000958	0.00108	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Epirubicin—liver cancer	0.000953	0.00107	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Doxorubicin—liver cancer	0.000952	0.00107	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Doxorubicin—liver cancer	0.000952	0.00107	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Doxorubicin—liver cancer	0.000952	0.00107	CcSEcCtD
Isosorbide Mononitrate—Anxiety—Doxorubicin—liver cancer	0.000948	0.00107	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Doxorubicin—liver cancer	0.00094	0.00106	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Epirubicin—liver cancer	0.00094	0.00106	CcSEcCtD
Isosorbide Mononitrate—Dry mouth—Doxorubicin—liver cancer	0.000931	0.00105	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Epirubicin—liver cancer	0.000921	0.00104	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Doxorubicin—liver cancer	0.00092	0.00103	CcSEcCtD
Isosorbide Mononitrate—Oedema—Doxorubicin—liver cancer	0.000912	0.00103	CcSEcCtD
Isosorbide Mononitrate—Infection—Doxorubicin—liver cancer	0.000906	0.00102	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000898	0.00101	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—SERPINA1—liver cancer	0.000898	0.0106	CbGpPWpGaD
Isosorbide Mononitrate—Shock—Doxorubicin—liver cancer	0.000897	0.00101	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Doxorubicin—liver cancer	0.000895	0.00101	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Doxorubicin—liver cancer	0.000893	0.001	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.000892	0.0105	CbGpPWpGaD
Isosorbide Mononitrate—Insomnia—Epirubicin—liver cancer	0.000892	0.001	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Doxorubicin—liver cancer	0.00089	0.001	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Doxorubicin—liver cancer	0.000886	0.000997	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Epirubicin—liver cancer	0.000885	0.000996	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Doxorubicin—liver cancer	0.000882	0.000992	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Epirubicin—liver cancer	0.000879	0.000989	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Epirubicin—liver cancer	0.000876	0.000986	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Doxorubicin—liver cancer	0.00087	0.000978	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Epirubicin—liver cancer	0.000868	0.000976	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.000864	0.0102	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.00086	0.0102	CbGpPWpGaD
Isosorbide Mononitrate—Decreased appetite—Epirubicin—liver cancer	0.000857	0.000964	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Doxorubicin—liver cancer	0.000852	0.000959	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Epirubicin—liver cancer	0.000851	0.000958	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Epirubicin—liver cancer	0.00085	0.000956	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.000849	0.01	CbGpPWpGaD
Isosorbide Mononitrate—Pain—Epirubicin—liver cancer	0.000843	0.000948	CcSEcCtD
Isosorbide Mononitrate—Constipation—Epirubicin—liver cancer	0.000843	0.000948	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000831	0.000935	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Doxorubicin—liver cancer	0.000825	0.000928	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Doxorubicin—liver cancer	0.000819	0.000921	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Doxorubicin—liver cancer	0.000813	0.000915	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Epirubicin—liver cancer	0.000812	0.000914	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Doxorubicin—liver cancer	0.000811	0.000912	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Epirubicin—liver cancer	0.000806	0.000907	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Doxorubicin—liver cancer	0.000803	0.000903	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.000795	0.0094	CbGpPWpGaD
Isosorbide Mononitrate—Decreased appetite—Doxorubicin—liver cancer	0.000793	0.000892	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000788	0.000886	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Doxorubicin—liver cancer	0.000786	0.000885	CcSEcCtD
Isosorbide Mononitrate—Pain—Doxorubicin—liver cancer	0.00078	0.000878	CcSEcCtD
Isosorbide Mononitrate—Constipation—Doxorubicin—liver cancer	0.00078	0.000878	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Epirubicin—liver cancer	0.000779	0.000877	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Epirubicin—liver cancer	0.000779	0.000877	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Doxorubicin—liver cancer	0.000752	0.000846	CcSEcCtD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—IFNA1—liver cancer	0.00075	0.00887	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—IFNA1—liver cancer	0.00075	0.00887	CbGpPWpGaD
Isosorbide Mononitrate—Gastrointestinal pain—Doxorubicin—liver cancer	0.000746	0.000839	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Epirubicin—liver cancer	0.000726	0.000817	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Doxorubicin—liver cancer	0.000721	0.000811	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Doxorubicin—liver cancer	0.000721	0.000811	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.00072	0.00851	CbGpPWpGaD
Isosorbide Mononitrate—Asthenia—Epirubicin—liver cancer	0.000707	0.000796	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Epirubicin—liver cancer	0.000697	0.000785	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—JUN—liver cancer	0.000693	0.0082	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.000692	0.00818	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.000688	0.00814	CbGpPWpGaD
Isosorbide Mononitrate—Diarrhoea—Epirubicin—liver cancer	0.000675	0.000759	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Doxorubicin—liver cancer	0.000672	0.000756	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—IFNA1—liver cancer	0.000669	0.00791	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PRKCE—liver cancer	0.000664	0.00785	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PRKCE—liver cancer	0.000664	0.00785	CbGpPWpGaD
Isosorbide Mononitrate—Asthenia—Doxorubicin—liver cancer	0.000654	0.000736	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Epirubicin—liver cancer	0.000652	0.000733	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Doxorubicin—liver cancer	0.000645	0.000726	CcSEcCtD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—ABL1—liver cancer	0.000631	0.00747	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—ABL1—liver cancer	0.000631	0.00747	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—IGF2—liver cancer	0.000629	0.00743	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—IGF2—liver cancer	0.000629	0.00743	CbGpPWpGaD
Isosorbide Mononitrate—Vomiting—Epirubicin—liver cancer	0.000627	0.000705	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Doxorubicin—liver cancer	0.000624	0.000702	CcSEcCtD
Isosorbide Mononitrate—Rash—Epirubicin—liver cancer	0.000622	0.000699	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Epirubicin—liver cancer	0.000621	0.000699	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.000618	0.00731	CbGpPWpGaD
Isosorbide Mononitrate—Headache—Epirubicin—liver cancer	0.000618	0.000695	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Doxorubicin—liver cancer	0.000603	0.000679	CcSEcCtD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—HGF—liver cancer	0.000594	0.00702	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—HGF—liver cancer	0.000594	0.00702	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.000593	0.00702	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PRKCE—liver cancer	0.000591	0.00699	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—CSF2—liver cancer	0.000587	0.00694	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—CSF2—liver cancer	0.000587	0.00694	CbGpPWpGaD
Isosorbide Mononitrate—Nausea—Epirubicin—liver cancer	0.000586	0.000659	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Doxorubicin—liver cancer	0.00058	0.000652	CcSEcCtD
Isosorbide Mononitrate—Rash—Doxorubicin—liver cancer	0.000575	0.000647	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Doxorubicin—liver cancer	0.000575	0.000646	CcSEcCtD
Isosorbide Mononitrate—Headache—Doxorubicin—liver cancer	0.000571	0.000643	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—ABL1—liver cancer	0.000563	0.00666	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.000562	0.00665	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—IGF2—liver cancer	0.00056	0.00663	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000549	0.00649	CbGpPWpGaD
Isosorbide Mononitrate—Nausea—Doxorubicin—liver cancer	0.000542	0.00061	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.000539	0.00637	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—HGF—liver cancer	0.000529	0.00626	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—CSF2—liver cancer	0.000523	0.00619	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.000517	0.00611	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.000497	0.00588	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—MAPK14—liver cancer	0.000475	0.00562	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—MAPK14—liver cancer	0.000475	0.00562	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000471	0.00557	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—F2—liver cancer	0.000461	0.00545	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—F2—liver cancer	0.000461	0.00545	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000445	0.00526	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CG—liver cancer	0.000441	0.00521	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CG—liver cancer	0.000441	0.00521	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—MAPK14—liver cancer	0.000424	0.00501	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL6—liver cancer	0.000419	0.00495	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—F2—liver cancer	0.000411	0.00486	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000404	0.00478	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CG—liver cancer	0.000393	0.00465	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CD—liver cancer	0.000388	0.00458	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CD—liver cancer	0.000388	0.00458	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—SERPINE1—liver cancer	0.000383	0.00453	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—SERPINE1—liver cancer	0.000383	0.00453	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—ALB—liver cancer	0.000383	0.00452	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—ALB—liver cancer	0.000383	0.00452	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.00037	0.00437	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—RAF1—liver cancer	0.000346	0.00409	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—RAF1—liver cancer	0.000346	0.00409	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CD—liver cancer	0.000345	0.00408	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—SERPINE1—liver cancer	0.000342	0.00404	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—ALB—liver cancer	0.000341	0.00403	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CB—liver cancer	0.000338	0.00399	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CB—liver cancer	0.000338	0.00399	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—IL2—liver cancer	0.00031	0.00367	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—IL2—liver cancer	0.00031	0.00367	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000309	0.00366	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—RAF1—liver cancer	0.000308	0.00365	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CB—liver cancer	0.000301	0.00356	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000299	0.00353	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000295	0.00349	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—IL2—liver cancer	0.000276	0.00327	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000266	0.00314	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—VEGFA—liver cancer	0.000264	0.00312	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—VEGFA—liver cancer	0.000264	0.00312	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000256	0.00302	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000242	0.00286	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—TGFB1—liver cancer	0.000242	0.00286	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—TGFB1—liver cancer	0.000242	0.00286	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000236	0.00279	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—VEGFA—liver cancer	0.000235	0.00278	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000232	0.00275	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000229	0.00271	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—KRAS—liver cancer	0.000224	0.00265	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—KRAS—liver cancer	0.000224	0.00265	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—TGFB1—liver cancer	0.000216	0.00255	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000215	0.00254	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000212	0.00251	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000212	0.00251	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000209	0.00248	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000207	0.00245	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CA—liver cancer	0.000206	0.00244	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CA—liver cancer	0.000206	0.00244	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—KRAS—liver cancer	0.0002	0.00236	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.0002	0.00236	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—TP53—liver cancer	0.000199	0.00236	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—TP53—liver cancer	0.000199	0.00236	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000197	0.00234	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000195	0.0023	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—HRAS—liver cancer	0.00019	0.00225	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—HRAS—liver cancer	0.00019	0.00225	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CA—liver cancer	0.000184	0.00217	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—TP53—liver cancer	0.000178	0.0021	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000174	0.00206	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—HRAS—liver cancer	0.00017	0.00201	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—AKT1—liver cancer	0.000168	0.00199	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—AKT1—liver cancer	0.000168	0.00199	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000166	0.00196	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000158	0.00187	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—AKT1—liver cancer	0.00015	0.00177	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000129	0.00152	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000127	0.0015	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000118	0.0014	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000106	0.00126	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000105	0.00124	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTM1—liver cancer	9.75e-05	0.00115	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	9.62e-05	0.00114	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP1A1—liver cancer	9.25e-05	0.00109	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	9.12e-05	0.00108	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—UGDH—liver cancer	6.91e-05	0.000818	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—EPT1—liver cancer	6.5e-05	0.000769	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—TAT—liver cancer	6.16e-05	0.000729	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GLUL—liver cancer	4.19e-05	0.000495	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CPT1B—liver cancer	4.19e-05	0.000495	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NR1H4—liver cancer	4.04e-05	0.000478	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTA3—liver cancer	3.97e-05	0.00047	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTA4—liver cancer	3.63e-05	0.00043	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTA2—liver cancer	3.54e-05	0.000419	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTA1—liver cancer	3.42e-05	0.000404	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NAT2—liver cancer	3.38e-05	0.000399	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ALDOB—liver cancer	3.24e-05	0.000383	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CRABP1—liver cancer	3.09e-05	0.000365	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—HPGDS—liver cancer	2.7e-05	0.000319	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PSMA4—liver cancer	2.41e-05	0.000285	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PSMD10—liver cancer	2.41e-05	0.000285	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GOT2—liver cancer	2.34e-05	0.000277	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP2E1—liver cancer	2.2e-05	0.00026	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYCS—liver cancer	2.06e-05	0.000244	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GOT1—liver cancer	2.02e-05	0.000239	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GGT1—liver cancer	2.02e-05	0.000239	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTP1—liver cancer	1.81e-05	0.000215	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—HMOX1—liver cancer	1.79e-05	0.000212	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTM1—liver cancer	1.67e-05	0.000197	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP1A1—liver cancer	1.58e-05	0.000187	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—MTHFR—liver cancer	1.47e-05	0.000174	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PPARA—liver cancer	1.45e-05	0.000171	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CG—liver cancer	1.24e-05	0.000146	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PPARG—liver cancer	1.2e-05	0.000141	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CD—liver cancer	1.09e-05	0.000129	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ALB—liver cancer	1.07e-05	0.000127	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CB—liver cancer	9.49e-06	0.000112	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CA—liver cancer	5.78e-06	6.84e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—AKT1—liver cancer	4.73e-06	5.59e-05	CbGpPWpGaD
